Molecular mechanisms involved in the regulation of certain miRNAs in breast cancer cells and cancer-associated fibroblasts
Mostra/ Apri
Creato da
Sebastiani, Anna
Maggiolinu, Marcello
Cerra, Maria Carmela
Metadata
Mostra tutti i dati dell'itemDescrizione
Formato
/
Università della Calabria. Dipartimento di Biologia, Ecologia e Scienze della Terra
Dottorato di Ricerca in Scienze della Vita.
XXXII Ciclo; MicroRNAs (miRNAs) are non-coding small RNA molecules that regulate gene expression by
inhibiting the translation of target mRNAs. It has been well demonstrated that miRNAs play a
regulatory role in different pathophysiological conditions, including breast cancer. In this
regard, a distinct miRNA may be up regulated in certain malignancies and downregulated in
others, suggesting both an oncogenic and tumor suppressor role, respectively. It has also
reported that in breast cancer estrogens may regulate miRNA expression through the
involvement of the classic estrogen receptor (ER) alpha and the G protein coupled receptor,
GPER.
By using RT-PCR and western blotting assays, as well as by gene silencing approaches, in the
present work we provide novel insights on the involvement of miRNAs in the breast tumor
progression. In particular, we ascertained that miR-221 expression is up-regulated in breast
cancer cells SkBr3 and MDA-MB 231 and in cancer-associated fibroblasts (CAFs). In addition,
we found that the proliferative and migratory effects induced by miR-221 in these cell types are
mediated by interfering the A20/c-Rel/CTGF pathway. These stimulatory effects are abolished
silencing the expression of the NF-κB component, c-Rel and the Connective Tissue Growth
Factor (CTGF), as well as using the specific Locked Nucleic Acid (LNA)-Inhibitor of miR-221
(LNA-i-miR-221).
In a second work, we evaluated the expression of 754 miRNAs by TaqMan Array in ER-negative
and GPER-positive SkBr3 breast cancer cells and in CAFs upon 17-β-estradiol (E2) treatment.
Among the miRNAs down-regulated by 100nM E2 for 4 hours in these cell types, we identified
miR-338-3p that is positively correlated with overall survival in breast cancer patients as
ascertained by METABRIC database analysis. According to these data, a miR-338-3p mimic
sequence decreased and a miR-338-3p inhibitor sequence rescued the proliferative effects and
cell progression induced by 100nM E2 and G-1, selective ligand of GPER in SkBr3 breast
cancer cells and CAFs.
Overall, these results provide new insights on the miRNA action in breast cancer, suggesting
their use as an innovative therapeutic approach in this malignancy.Soggetto
Breast cancer; Estrogens; GPER
Relazione
MED/04;